February 18, 2021
OXFORD, England, Feb. 18, 2021 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has raised £69.2 million ($95.4 million) in a Series C financing round. The financing was significantly oversubscribed with high...
Source URL: https://www.prnewswire.com:443/news-releases/evox-therapeutics-completes-69-2-million-series-c-financing-301230102.html
|
